Omron and AliveCor combine patient monitoring technology
May 5, 2020
California-based AliveCor is combining its personal ECG technology with blood pressure devices from Japanese firm Omron Healthcare to expand access to remote patient care. The companies also announced the closing of an equity investment by Omron in AliveCor.
This partnership aligns with global trends to deploy non-invasive remote monitoring devices to facilitate patient monitoring while reducing patient and healthcare provider contact during the current pandemic.
"At AliveCor, we are committed to providing life-saving cardiological services to those who need them most," said AliveCor CEO Priya Abani. “The scope, scale and strategic importance of this transaction are unprecedented in our corporate history. Omron's enormous R&D and distribution resources will bring AliveCor technology to more markets and more end users than ever before."
The Covid-19 pandemic underscores the importance of telemedicine in how people care for themselves and loved ones. Those with chronic illness, including heart disease, are at higher risk of infection. AliveCor and Omron serve this vulnerable population every day by allowing patients to send personal health data to physicians without leaving their homes. The companies' ability to provide medical-grade technologies at home can offer peace of mind to their users.
"The integration of these complementary technologies allows us to expand the heart health data we provide our customers and physician partners for a more complete picture of a patient's heart health," said Isao Ogino, president and CEO of Omron Healthcare. "Our mission is going for zero heart attacks and strokes. It is a lofty goal and we have committed to combining forces with like-minded partners to achieve it. Omron has already made important strides with AliveCor to advance our mission and this expansion of that collaboration, including the development of remote patient monitoring services, is a valuable boost to our growing healthcare portfolio."
The first technology collaboration between the two companies was the FDA cleared Omron Complete, a blood pressure monitor with ECG capability in a single device. The companies expect this product to be the first in a line of integrated ECG and blood pressure devices making home heart care more accessible to consumers.
AliveCor is transforming cardiological care using deep learning. The FDA-cleared KardiaMobile device provides instant detection of atrial fibrillation, bradycardia, tachycardia and normal rhythm in an ECG. The AI enabled platform aids patients and clinicians in the early detection of atrial fibrillation, the most common arrhythmia and one associated with a highly elevated risk of stroke.
AliveCor is a privately-held company headquartered in Mountain View, California.